Skip to main content
Caplight Logo









LEAF4Life

LEAF4Life

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://leafforlife.com/

Last Round

Series B

Dec 14, 2022

Est. Valuation

$110M

Total Funding Raised

$43.47M

Company Overview

LEAF4Life is a biopharmaceutical company that develops innovative oxygenation therapies to treat hypoxia-related disorders and conditions caused by pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discoveryliposomal formulationhypoxia therapyacute respiratory distress syndromeARDStranscrocetinclinical trialsoxygen deliverybiotech startupmicrocirculatory repairtherapeutic developmentdrug pipelinenanomedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LEAF4Life Comparables

Compare LEAF4Life with similar companies based on industry and business-model similarity.

LEAF4Life comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CervoMed Inc.
82%
NuvOx Therapeutics
79%
Prolong Pharmaceuticals, LLC
78%

LEAF4Life Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 14, 2022
Series BMay 5, 2021

Key People

Founding team and executive leadership

Clet Niyikiza

Founder, Chairman CEO

Founding Team

LEAF4Life Investors

Notable investors and investment history

LEAF4Life investors
InvestorRounds
Purpose Venture CapitalSeries B
GaingelsSeries B
Infinitas CapitalSeries B
Korify CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 267% MoM, reaching 841.

  • May 16, 2026

    Monthly visitors increased 513% MoM.

LEAF4Life Filings

Explore SEC and related filing metadata, where available.

LEAF4Life filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LEAF4Life's valuation, stock price, and market status.

Is LEAF4Life a public or private company?

LEAF4Life is a private company.

What is the current stock price of LEAF4Life?

LEAF4Life is a private company with no public stock price. No recent secondary market data is available.

How much is LEAF4Life worth (valuation)?

LEAF4Life's valuation is estimated at $110.0M based on funding round data.

Can I buy LEAF4Life stock?

LEAF4Life shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LEAF4Life's last funding round?

LEAF4Life's most recent funding round was Series B on May 5, 2021.

Who are the main investors in LEAF4Life?

Key investors in LEAF4Life include Purpose Venture Capital, Gaingels, Infinitas Capital, Korify Capital.

Will LEAF4Life IPO soon?

No public IPO plans have been announced for LEAF4Life.

How can I track LEAF4Life secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LEAF4Life's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWoburn, Massachusetts
Employee Range1
Year Founded2018
Last FundingDec 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?